David McIntosh/LinkedIn
Oct 4, 2026, 14:41
David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
“International Plasma Awareness Week 2026
Words well worth sharing!
Raphaela Vedia and millions of fellow rare disease sufferers all over the World are eternally grateful to Blood and Plasma Donors for the life-saving medicines they make possible.
So why do we need to know?
Because:
- Globally, we need four times as many donations as are currently being collected
- In many Low and Middle Income Countries, there are no facilities for pure plasma donation – and too little capacity for the recovery of plasma from blood donations
- Hundreds of millions of rare disease sufferers therefore have to struggle on without the plasma-derived medicines they need
- The unnecessary suffering and avoidable mortality this causes are shocking and shameful
All of us with any hope of making a difference should please do our bit.”
More posts featuring David McIntosh on Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series